It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Timing your investments in stocks vs bonds can significantly impact returns. Learn when to make your moves.
13,124 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
As mid-2026 trading picks up, McDonald’s demonstrates stronger growth and cash flow versus Pfizer, which relies on in...
The first half of 2026 handed investors a harsh lesson on how fast sentiment can turn in ad tech. This article breaks...
As Netflix faces slowing growth, the question on investors' minds is simple: could the streamer be about to buy somet...
Five of america's biggest banks kick off a pivotal earnings week. Here's what to watch as each reports and how the re...
A high‑income ETF pays roughly 10% by writing options on Nasdaq-100 stocks, Nvidia among them. The strategy offers st...
Wall Street bets big on SpaceX, pricing in rapid expansion across launches, Starlink, and new ventures. This guide br...
The KORU 3X South Korea Bull ETF jumps on a memory stock rally after SK Hynix confirms mass production of HBM4 for NV...
PayPal shares surged following unconfirmed reports of a joint takeover bid by Stripe and Advent International, valued...
A low-cost S&P 500 ETF has been selected for Trump accounts, with potential inflows of up to $30 billion as investors...
Micron Technology sits around $905 as the AI memory stock rally faces questions. Here are three reasons investors may...
A cyberattack compromised airbnb brian chesky’s account on X this week, circulating AI-driven posts about real-world ...